Serious Event

Serious Event

Serious Adverse Events (SAEs) are adverse events that result in death, are life-threatening, require or prolong hospitalization, cause persistent or significant disability/incapacity, or are congenital anomalies/birth defects. Each serious event is categorized by term, organ system, assessment type, and source vocabulary to provide standardized reporting across clinical trials.

Serious Event path is as follows:

Study -> Results Section -> Adverse Events Module -> Serious Event

Study -> Results Section -> Adverse Events Module -> Serious Event -> Serious Event Stats

Serious Event


Ignite Creation Date: 2025-12-24 @ 12:42 PM
Ignite Modification Date: 2025-12-25 @ 12:13 PM
NCT ID: NCT00604461
Term: Death
Organ System: General disorders
Assessment Type: SYSTEMATIC_ASSESSMENT
Source Vocabulary: CTCAE V3
Notes: One patient died within 30 days of starting treatment from an unidentified cause.
Study: NCT00604461
Study Brief: Carboplatin, Bevacizumab and Pemetrexed in the First-Line Treatment of Patients With Malignant Pleural Mesothelioma (MPM)
Serious Event Stats (If Any):

Serious Event Stats

Group ID # Events # Affected # At Risk View
EG000 1 1 13 View